Author:
Mohapatra Debabrata,Seth Rachna,Mallick Saumyaranjan
Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. WHO Classification of Tumours series;WHO Classification of Tumours Editorial Board.,2022
2. International Agency for Research on Cancer. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. WHO Classification of Tumours, Revised 4th Edition, Volume 2 [Internet]. Accessed on July 22, 2023. Available from: https://publications.iarc.fr/Book-And-Report-Series/Who-Classfication-Of-Tumours/WHO-Classification-Of-Tumours-Of-Haematopoietic-And-Lymphoid-Tissues-2017
3. Alaggio R, Amador C, Anagnostopoulos I, et al. The 5th edition of the World Health Organization Classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720–48.
4. Thol F. ALL is not the same in the era of genetics. Blood. 2021;138:915–6.
5. Eichenauer DA, Engert A. Nodular lymphocytepredominant Hodgkin lymphoma: a unique disease deserving unique management. Hematology Am Soc Hematol Educ Program. 2017;2017:324–8.